Sector Update: Health Care Stocks Decline Pre-Bell Friday

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Sector Update: Health Care Stocks Decline Pre-Bell Friday

, MT Newswires - 9:13 AM ET 4/4/2025 default

09:13 AM EDT, 04/04/2025 (MT Newswires) -- Health care stocks were declining pre-bell Friday, with The Health Care Select Sector SPDR Fund ( XLV ) down 0.5% and the iShares Biotechnology ETF (IBB) 1.6% lower.

Mesoblast (MESO) said it considers its allogeneic cellular therapies, including Ryoncil and Revascor, to be US-origin products that will not be subject to tariffs. Shares of Mesoblast were down more than 7% premarket.

AbbVie ( ABBV ) shares were down 1.2% after the company issued Q1 adjusted earnings guidance below analysts' expectations and lowered its 2025 adjusted EPS outlook.

Amgen ( AMGN ) shares were over 1% higher after the company said the US Food and Drug Administration approved Uplizna as treatment for adults with immunoglobulin G4-related disease, a chronic immune-mediated inflammatory condition that can damage multiple organs.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.